Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03243331
Title An Initial Safety Study of Gedatolisib Plus PTK7-ADC for Metastatic Triple-negative Breast Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Kathy Miller
Indications

triple-receptor negative breast cancer

Therapies

Cofetuzumab pelidotin + Gedatolisib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.